These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21527654)

  • 1. Commentary.
    Milone MC
    Clin Chem; 2011 May; 57(5):674. PubMed ID: 21527654
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary.
    Butch AW
    Clin Chem; 2011 May; 57(5):673. PubMed ID: 21527653
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased cyclosporine concentrations in the absence of cyclosporine administration.
    Peter A; Shipkova M; Wieland E; Schleicher E; Müller I
    Clin Chem; 2011 May; 57(5):670-3. PubMed ID: 21527652
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropathy of metachromatic leukodystrophy: improvement with immunomodulation.
    Nevo Y; Pestronk A; Lopate G; Carroll SL
    Pediatr Neurol; 1996 Oct; 15(3):237-9. PubMed ID: 8916163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of leflunomide to reduce xenoantibody titers in vivo: an evaluation of the prolongation of discordant xenograft survival.
    Lucien J; Marath A; Rayat G; Thliveris J; Koshal A; Yatscoff R
    Transplant Proc; 1996 Apr; 28(2):704-7. PubMed ID: 8623356
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppression with leflunomide and cyclosporine prevents pig-to-rat islet xenograft rejection.
    Wennberg L; Wallgren AC; Sundberg B; Rafael E; Zhu S; Liu J; Tibell A; Karlsson-Parra A; Groth CG; Korsgren O
    Transplant Proc; 1995 Dec; 27(6):3314-5. PubMed ID: 8539967
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced efficacy of repeated anti-CD8 monoclonal antibody therapy by high-dose cyclosporine treatment.
    Allan JS; Slisz JK; Vesga L; Arn JS; Yamada K; Sachs DH; Madsen JC
    Transplant Proc; 1998 Dec; 30(8):4062-3. PubMed ID: 9865295
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the new AxSYM cyclosporine assay: comparison with TDx monoclonal whole blood and Emit cyclosporine assays.
    Wallemacq PE; Alexandre K
    Clin Chem; 1999 Mar; 45(3):432-5. PubMed ID: 10053055
    [No Abstract]   [Full Text] [Related]  

  • 9. Falsely increased blood tacrolimus concentrations using the ACMIA assay due to circulating endogenous antibodies in a liver transplant recipient: a tentative approach to obtaining reliable results.
    Hermida J; Tutor JC
    Ther Drug Monit; 2009 Apr; 31(2):269-72. PubMed ID: 19258927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of the Abbott cyclosporine monoclonal whole blood assay.
    Guinarte JC; Pérez LF; Tutor JC
    Clin Chem; 1998 Jul; 44(7):1581-2. PubMed ID: 9665452
    [No Abstract]   [Full Text] [Related]  

  • 11. Specimen dilution for C2 monitoring with the Abbott TDxFLx cyclosporine monoclonal whole blood assay.
    Juenke JM; Brown PI; Urry FM; McMillin GA
    Clin Chem; 2004 Aug; 50(8):1430-3. PubMed ID: 15277354
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-B cell agents: suppression of natural antibodies and prolongation of survival in discordant xenografts.
    Blakely ML; Van der Werf WJ; Dalmasso AP; Bach FH
    Transplant Proc; 1994 Jun; 26(3):1374-5. PubMed ID: 8029946
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cyclosporine].
    Yuhki Y; Tadano K; Takahashi Y
    Nihon Rinsho; 1999 Sep; 57 Suppl():428-31. PubMed ID: 10543145
    [No Abstract]   [Full Text] [Related]  

  • 14. The new immunosuppressive malononitrilamide MNA 279 prolongs skin xenograft survival in a mouse-to-rat model.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1997 Dec; 29(8):3497-500. PubMed ID: 9414810
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene delivery improvement for treating the lysosomal storage disorder metachromatic leukodystrophy.
    Ferraiuolo L; Kaspar BK
    Hum Gene Ther; 2012 Aug; 23(8):793-5. PubMed ID: 22900577
    [No Abstract]   [Full Text] [Related]  

  • 16. Technical limitations of immunosuppressive drug therapy blood level monitoring.
    Masri MA; Rizk S; Kamel G; Barbari A; Stephan A
    Transplant Proc; 2003 Nov; 35(7):2755-6. PubMed ID: 14612107
    [No Abstract]   [Full Text] [Related]  

  • 17. Is a lower dose of cyclosporine required among Iranian kidney transplant recipients?
    Nourbala MH; Heidari F
    Iran J Kidney Dis; 2012 Sep; 6(5):327-9. PubMed ID: 22976254
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of hepatitis C virus infection on cyclosporine trough levels in renal transplant patients.
    Tuncer M; Süleymanlar G; Ersoy FF; Yakupoğlu G
    Transplant Proc; 2000 May; 32(3):569-71. PubMed ID: 10812116
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppression with cyclosporin A in combination with leflunomide and mycophenolate mofetil prevents rejection of pig-islets transplanted into rats.
    Wennberg L; Wallgren AC; Sundberg B; Rafael E; Zhu S; Liu J; Tibell A; Karlsson-Parra A; Groth CG; Korsgren O
    Transplant Proc; 1996 Apr; 28(2):819. PubMed ID: 8623416
    [No Abstract]   [Full Text] [Related]  

  • 20. FPIA and EMIT methods compared for cyclosporine monitoring in heart transplant patients.
    Fatio R; Sütsch G; Pei P; Follath F; Kiowski W
    Clin Chem; 1998 Mar; 44(3):693-4. PubMed ID: 9510894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.